Antipsychotic-induced weight gain: can the energy balance gene variants help us tip the scales?
暂无分享,去创建一个
[1] C. McDougle,et al. Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies , 2013, Translational Psychiatry.
[2] J. Lieberman,et al. Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene , 2012, The Pharmacogenomics Journal.
[3] Annette Lee,et al. Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain. , 2012, Archives of general psychiatry.
[4] J. Lieberman,et al. Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[5] Xi-rong Guo,et al. Genetic Polymorphisms in Adipokine Genes and the Risk of Obesity: A Systematic Review and Meta‐Analysis , 2012, Obesity.
[6] Y. Tsai,et al. Polymorphisms of INSIG2, MC4R, and LEP Are Associated With Obesity- and Metabolic-Related Traits in Schizophrenic Patients , 2011, Journal of clinical psychopharmacology.
[7] T. Egberts,et al. Polymorphisms of the LEP, LEPR and HTR2C gene: obesity and BMI change in patients using antipsychotic medication in a naturalistic setting. , 2011, Pharmacogenomics.
[8] Young-Min Park,et al. Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine‐induced weight gain , 2011, Human psychopharmacology.
[9] L. V. Van Gaal,et al. Association study of MC4R with complex obesity and replication of the rs17782313 association signal. , 2011, Molecular genetics and metabolism.
[10] Peilin Jia,et al. Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs , 2010, Molecular Psychiatry.
[11] J. Vázquez-Barquero,et al. Effect of FTO, SH2B1, LEP, and LEPR Polymorphisms on Weight Gain Associated With Antipsychotic Treatment , 2010, Journal of clinical psychopharmacology.
[12] V. Fernández,et al. Polymorphisms of the LEP- and LEPR genes, metabolic profile after prolonged clozapine administration and response to the antidiabetic metformin , 2010, Schizophrenia Research.
[13] M. Maj,et al. Endocannabinoid Pro129Thr FAAH Functional Polymorphism But Not 1359G/A CNR1 Polymorphism Is Associated With Antipsychotic-Induced Weight Gain , 2010, Journal of clinical psychopharmacology.
[14] D. Müller,et al. Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample. , 2010, Pharmacogenomics.
[15] J. Lieberman,et al. A Common Polymorphism in the Cannabinoid Receptor 1 (CNR1) Gene is Associated with Antipsychotic-Induced Weight Gain in Schizophrenia , 2010, Neuropsychopharmacology.
[16] L. Ación,et al. Leptin Gene –2548G/A variants predict risperidone-associated weight gain in children and adolescents , 2009, Psychiatric genetics.
[17] S. Cooper,et al. Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia. , 2008, The British journal of psychiatry : the journal of mental science.
[18] Young-Min Park,et al. Possible association between the −2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[19] J. Olié,et al. Leptin and Ghrelin Levels in Patients With Schizophrenia During Different Antipsychotics Treatment: A Review , 2007, Schizophrenia bulletin.
[20] H. Nasrallah,et al. Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles , 2008, Molecular Psychiatry.
[21] J. Kennedy,et al. Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis. , 2007, The international journal of neuropsychopharmacology.
[22] Yan Shen,et al. Association of Clozapine-Induced Weight Gain With a Polymorphism in the Leptin Promoter Region in Patients With Chronic Schizophrenia in a Chinese Population , 2007, Journal of clinical psychopharmacology.
[23] Del D. Miller,et al. Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia. , 2007, Psychopharmacology bulletin.
[24] D. Cota,et al. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. , 2006, Endocrine reviews.
[25] J. Hebebrand,et al. Clozapine-induced weight gain: a study in monozygotic twins and same-sex sib pairs , 2005, Psychiatric genetics.
[26] G. Reynolds,et al. Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis , 2005, Pharmacogenetics and genomics.
[27] R. Weizman,et al. Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study. , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.
[28] R. Leadbetter,et al. Clozapine-induced weight gain. , 1990, The American journal of psychiatry.